ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,910, issued on July 15, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Heteroaromatic compounds as Vanin inhibitors" was invented by Cedrickx Godbout (Attenweiler, Germany), Martin Thomas Fleck (Munich) and Hannes Fiepko Koolman (Biberach an der Riss, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention encompasses compounds of the formula Iwhich are suitable for the treatment of diseases related to Vanin, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use."
The patent was filed on Dec. 2, 2019, under Application ...